Evaluating Drug Distribution to the Central Nervous System Via Imaging & Molecular Modalities
2:00 pm - Wednesday 2nd December 2026
- A review of current methodologies used to measure drug biodistribution in the CNS, including terminal and non-terminal modalities
- Advantages/disadvantages of common modalities, including optical imaging, PET/CT, ELISA, and PCR
- Translation of methodologies across species/challenges in larger animal models, including differences in BBB permeability, CSF turnover and volume
